| Guidelines on nicotine dose selection for in vivo research SG Matta, DJ Balfour, NL Benowitz, RT Boyd, JJ Buccafusco, ... Psychopharmacology 190, 269-319, 2007 | 909 | 2007 |
| Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects G Sanacora, MA Smith, S Pathak, HL Su, PH Boeijinga, DJ McCarthy, ... Molecular psychiatry 19 (9), 978-985, 2014 | 249 | 2014 |
| Selective α7 nicotinic receptor activation by AZD0328 enhances cortical dopamine release and improves learning and attentional processes S Sydserff, EJ Sutton, D Song, MC Quirk, C Maciag, C Li, G Jonak, ... Biochemical pharmacology 78 (7), 880-888, 2009 | 117 | 2009 |
| A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression EM Richards, DC Mathews, DA Luckenbaugh, DF Ionescu, ... Psychopharmacology 233, 1119-1130, 2016 | 86 | 2016 |
| Effects of drugs of abuse and cholinergic agents on delayed matching-to-sample responding in the squirrel monkey. TJ Hudzik, GR Wenger Journal of Pharmacology and Experimental Therapeutics 265 (1), 120-127, 1993 | 75 | 1993 |
| Preclinical pharmacology of AZD2327: a highly selective agonist of the δ-opioid receptor TJ Hudzik, C Maciag, MA Smith, R Caccese, MR Pietras, KH Bui, ... Journal of Pharmacology and Experimental Therapeutics 338 (1), 195-204, 2011 | 67 | 2011 |
| Drug tolerance: a known unknown in translational neuroscience A Bespalov, R Müller, AL Relo, T Hudzik Trends in pharmacological sciences 37 (5), 364-378, 2016 | 57 | 2016 |
| Long-term functional end points following middle cerebral artery occlusion in the rat TJ Hudzik, A Borrelli, P Bialobok, D Widzowski, S Sydserff, A Howell, ... Pharmacology Biochemistry and Behavior 65 (3), 553-562, 2000 | 57 | 2000 |
| T2‐Weighted MRI Correlates with Long‐Term Histopathology, Neurology Scores, and Skilled Motor Behavior in a Rat Stroke Model GC Palmer, J Peeling, D Corbett, MR Del BIGIO, TJ Hudzik Annals of the New York Academy of Sciences 939 (1), 283-296, 2001 | 56 | 2001 |
| Behavioral pharmacology of AR-A000002, a novel, selective 5-hydroxytryptamine1B antagonist TJ Hudzik, M Yanek, T Porrey, J Evenden, C Paronis, M Mastrangelo, ... Journal of Pharmacology and Experimental Therapeutics 304 (3), 1072-1084, 2003 | 52 | 2003 |
| Translational biomarkers of neurotoxicity: a health and environmental sciences institute perspective on the way forward RA Roberts, M Aschner, D Calligaro, TR Guilarte, JP Hanig, DW Herr, ... Toxicological Sciences 148 (2), 332-340, 2015 | 49 | 2015 |
| Preclinical profile of a novel metabotropic glutamate receptor 5 positive allosteric modulator N Spear, RA Gadient, DE Wilkins, ML Do, JS Smith, KL Zeller, ... European journal of pharmacology 659 (2-3), 146-154, 2011 | 47 | 2011 |
| Antiparkinson potential of δ-opioid receptor agonists TJ Hudzik, A Howell, K Payza, AJ Cross European journal of pharmacology 396 (2-3), 101-107, 2000 | 46 | 2000 |
| Synthesis of novel quinolone and quinoline-2-carboxylic acid (4-morpholin-4-yl-phenyl) amides: A late-stage diversification approach to potent 5HT1B antagonists CL Horchler, JP McCauley Jr, JE Hall, DH Snyder, WC Moore, TJ Hudzik, ... Bioorganic & Medicinal Chemistry 15 (2), 939-950, 2007 | 45 | 2007 |
| Quetiapine and its metabolite norquetiapine: translation from in vitro pharmacology to in vivo efficacy in rodent models AJ Cross, D Widzowski, C Maciag, A Zacco, T Hudzik, J Liu, S Nyberg, ... British journal of pharmacology 173 (1), 155-166, 2016 | 43 | 2016 |
| Long-term deficits following cerebral hypoxia–ischemia in four-week-old rats: correspondence between behavioral, histological, and magnetic resonance imaging assessments UI Tuor, TJ Hudzik, K Malisza, S Sydserff, P Kozlowski, MR Del Bigio Experimental neurology 167 (2), 272-281, 2001 | 35 | 2001 |
| Rat middle cerebral artery occlusion: correlations between histopathology, T2-weighted magnetic resonance imaging, and behavioral indices J Peeling, D Corbett, MR Del Bigio, TJ Hudzik, TM Campbell, GC Palmer Journal of Stroke and Cerebrovascular Diseases 10 (4), 166-177, 2001 | 32 | 2001 |
| Rat brain-uptake index for phenylethylamine and various monomethylated derivatives AD Mosnaim, OH Callaghan, T Hudzik, ME Wolf Neurochemical research 38, 842-846, 2013 | 30 | 2013 |
| The Low‐Affinity, Use‐Dependent NMDA Receptor Antagonist AR‐R 15896AR: An Update of Progress in Stroke GC Palmer, EF Cregan, P Bialobok, SG Sydserff, TJ Hudzik, ... Annals of the New York Academy of Sciences 890 (1), 406-420, 1999 | 26 | 1999 |
| Effects of anticonvulsants in a novel operant learning paradigm in rats: Comparison of remacemide hydrochloride and FPL 15896AR to other anticonvulsant agents TJ Hudzik, GC Palmer Epilepsy research 21 (3), 183-193, 1995 | 24 | 1995 |
Dan WidzowskiAssociate Professor Indiana University of Pennsylvania在 iup.edu 的电子邮件经过验证
